Study of luteal function.

P N Barri; B Acauan; M Galvez; J Sabater; M Pardo; J Sentís; H Tolosa; A Laíz

PubMed · 6686914

Study of luteal function.

P N Barri·B Acauan·M Galvez·J Sabater·M Pardo·J Sentís·H Tolosa·A Laíz

Abstract

On studying various parameters of luteal function, the authors demonstrated that BTT does not permit the evaluation of luteal phase defects, whereas the E.I. and prolactin levels, as well as the endometrial biopsy, may be considered valid parameters. The TRH test is more efficient than basal prolactin evaluation in this respect. Progesterone should be evaluated in various moments of the luteal phase and not by a single determination. The authors conclude that the abnormal luteal phase is the result of an abnormal follicular maturation and that the central origin of this mechanism may be affirmed.

Explore related subjects

Biopsy Body Temperature Regulation Corpus Luteum Endometrium Estradiol Female Galactorrhea Humans Infertility, Female Menstruation Pregnancy Progesterone Prolactin Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

P N Barri, B Acauan, M Galvez, J Sabater, M Pardo, J Sentís, H Tolosa, A Laíz. Study of luteal function.. https://pubmed.ncbi.nlm.nih.gov/6686914/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1998

Absence of p53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein.

Mutations of the tumor-suppressor gene p53 are common in epithelial tumors. Clonal mutations of p53 have been found in cervical and vulvar carcinomas negative for human papillomavirus (HPV), though at least in cervical cancer HPV infection and p53 mutations are not mutually exclusive. We have previously shown that about 40% of male genital warts and bowenoid papulosis lesions exhibit immunohistochemically detectable aberrant p53 protein, irrespective of the presence of HPV DNA. We studied p53 mutations in exons 4-8 with SSCP and sequencing in 13 male patients with 1 to 3 therapy-resistant genital warts or intra-epithelial neoplasias each and in 4 patients with penile squamous cell carcinoma. Thus, 13 genital warts, 6 bowenoid papulosis, 1 Queyrat's erythroplasia and 1 carcinoma in situ were studied. p53 protein was detected immunohistochemically, and HPV status was analyzed with DNA in situ hybridization and amplification of HPV-specific DNA. There was no correlation between p53 protein expression and HPV status. No mutations in exons 5-8 of the p53 gene were found in any of the lesions, and furthermore, no exon 4 mutations were found in lesions positive in p53 immunohistochemistry. In conclusion, overexpression of p53 does not indicate a p53 mutation in male genital warts, pre-malignant lesions or malignant squamous cell carcinomas. Our study thus suggests that p53 mutations are not important, or at least not early, events in male genital carcinogenesis.

Biopsy↗

PubMed1998

Right bundle branch block, persistent ST-segment elevation, and sudden death.

Explore the source record for details and available documents.

Biopsy↗

PubMed1998

Whipple's disease - current status of diagnostics and therapy.

Whipple's disease is a multisystemic infectious disease whose pathogen, a gram-unstable actinomycete, has been characterized in the meantime by molecular-biological techniques (polymerase chain reaction). This infectious disease which was firstly described in 1907 by G.H. Whipple as intestinal lipodystrophy appears rarely and sporadically and can affect nearly every organ, in the course of which the small intestine is also concerned in the majority of patients. The symptoms and signs are polymorphous and depend on organic involvement and stage. This leads to significant difficulties concerning differential diagnosis and to a delay in diagnosis. Misjudging the syndromes provokes invalidism and death whereas correct therapy leads to a cure in most of the cases.

Biopsy↗